Site monitoring visits are to ensure compliance with protocol, Good Clinical Practice, Federal and local regulations and SOP’s. Regular site monitoring visits can be pre-study visits, initiation visits, periodic monitoring visits, and close-out visits. Study sites may also be monitored or audited by the FDA, Clinical Research Organizations (CROs), IRBs and sponsors.